nasal decongestants

Summary

Summary: Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993)

Top Publications

  1. ncbi [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa]
    S Knipping
    Universitätsklinik und Poliklinik für Hals, Nasen und Ohrenheilkunde, Kopf und Halschirurgie, Martin Luther Universitat Halle Wittenberg
    HNO 54:742-8. 2006
  2. ncbi Relationship between rhinitis duration and response to nasal decongestion test
    Giorgio Ciprandi
    Department of Internal Medicine, Azienda Ospedaliera Universitaria San Martino, Genoa, Italy
    Laryngoscope 118:1139-41. 2008
  3. ncbi Comparison of the clinical efficacy of standard and mucoadhesive-based nasal decongestants
    Christo T Tzachev
    Department of Industrial Pharmacy, Faculty of Pharmacy, Medical University, Sofia, Bulgaria
    Br J Clin Pharmacol 53:107-9. 2002
  4. ncbi alpha2-adrenoceptor agonists as nasal decongestants
    M R Corboz
    Pulmonary and Peripheral Neurobiology, Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA
    Pulm Pharmacol Ther 20:149-56. 2007
  5. ncbi Nasal decongestants in the treatment of chronic nasal obstruction: efficacy and safety of use
    Desiderio Passali
    Chief Professor, ENT Clinic University of Siena Medical School, Policlinico Le Scotte Viale Bracci, 53100 Siena, Italy
    Expert Opin Drug Saf 5:783-90. 2006
  6. ncbi Clinical assessment of a nasal decongestion test by visual analog scale in allergic rhinitis
    Giorgio Ciprandi
    Azienda Ospedaliera Universitaria San Martino, Genoa, Italy
    Am J Rhinol 22:502-5. 2008
  7. ncbi Pediatric allergic rhinitis: treatment
    Lien Lai
    Department of Medicine, Creighton University Medical Center, 601 North 30th Street, Suite 5850, Omaha, NE 68131 USA
    Immunol Allergy Clin North Am 25:283-99, vi. 2005
  8. ncbi Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus budesonide nasal spray in the management of nasal congestion in allergic rhinitis
    Ursula P Zieglmayer
    ENT - University Clinic Vienna, Vienna, Austria
    Treat Respir Med 4:283-7. 2005
  9. ncbi The value of Ems Mineral Salts in the treatment of rhinosinusitis in children. Prospective study on the efficacy of mineral salts versus xylometazoline in the topical nasal treatment of children
    O Michel
    Klinik u Poliklinik für HNO Heilkunde, Klinikum der Universität zu Köln, Kerpenerstr 62, 50924 Köln, Germany
    Int J Pediatr Otorhinolaryngol 69:1359-65. 2005
  10. ncbi Nasal wall compliance in vasomotor rhinitis
    Jean François Papon
    Physiopathologie et Thérapeutique Respiratoires INSERM UMR 651, Creteil, France
    J Appl Physiol 100:107-11. 2006

Research Grants

Detail Information

Publications135 found, 100 shown here

  1. ncbi [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa]
    S Knipping
    Universitätsklinik und Poliklinik für Hals, Nasen und Ohrenheilkunde, Kopf und Halschirurgie, Martin Luther Universitat Halle Wittenberg
    HNO 54:742-8. 2006
    ..Nasal obstruction is caused by rebound swelling when the decongestive effect has disappeared. The patient starts using nasal drops more frequently as a result of tachyphylaxis...
  2. ncbi Relationship between rhinitis duration and response to nasal decongestion test
    Giorgio Ciprandi
    Department of Internal Medicine, Azienda Ospedaliera Universitaria San Martino, Genoa, Italy
    Laryngoscope 118:1139-41. 2008
    ..The purpose of the study was to evaluate the impact of the duration of rhinitis on the response to nasal decongestion test in a cohort of patients with PER...
  3. ncbi Comparison of the clinical efficacy of standard and mucoadhesive-based nasal decongestants
    Christo T Tzachev
    Department of Industrial Pharmacy, Faculty of Pharmacy, Medical University, Sofia, Bulgaria
    Br J Clin Pharmacol 53:107-9. 2002
    ..It also caused fewer side effects...
  4. ncbi alpha2-adrenoceptor agonists as nasal decongestants
    M R Corboz
    Pulmonary and Peripheral Neurobiology, Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA
    Pulm Pharmacol Ther 20:149-56. 2007
    ....
  5. ncbi Nasal decongestants in the treatment of chronic nasal obstruction: efficacy and safety of use
    Desiderio Passali
    Chief Professor, ENT Clinic University of Siena Medical School, Policlinico Le Scotte Viale Bracci, 53100 Siena, Italy
    Expert Opin Drug Saf 5:783-90. 2006
    b>Nasal decongestants are the most powerful drugs in the reduction of nasal obstruction. Despite their large use, local and systemic adverse reactions are frequent...
  6. ncbi Clinical assessment of a nasal decongestion test by visual analog scale in allergic rhinitis
    Giorgio Ciprandi
    Azienda Ospedaliera Universitaria San Martino, Genoa, Italy
    Am J Rhinol 22:502-5. 2008
    ..The aim of this study was to verify the suitability of the use of the visual analog scales (VASs) as a surrogate for rhinomanometry in the decongestion test assessment in patients with persistent allergic rhinitis...
  7. ncbi Pediatric allergic rhinitis: treatment
    Lien Lai
    Department of Medicine, Creighton University Medical Center, 601 North 30th Street, Suite 5850, Omaha, NE 68131 USA
    Immunol Allergy Clin North Am 25:283-99, vi. 2005
    ..Immunotherapy generally is reserved for patients unresponsive to therapy or unable to take medications...
  8. ncbi Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus budesonide nasal spray in the management of nasal congestion in allergic rhinitis
    Ursula P Zieglmayer
    ENT - University Clinic Vienna, Vienna, Austria
    Treat Respir Med 4:283-7. 2005
    ..Both medications were well-tolerated. Cetirizine/pseudoephedrine was more effective than budesonide during HDM exposure, whereas budesonide became as effective as cetirizine/pseudoephedrine several hours post exposure to the allergens...
  9. ncbi The value of Ems Mineral Salts in the treatment of rhinosinusitis in children. Prospective study on the efficacy of mineral salts versus xylometazoline in the topical nasal treatment of children
    O Michel
    Klinik u Poliklinik für HNO Heilkunde, Klinikum der Universität zu Köln, Kerpenerstr 62, 50924 Köln, Germany
    Int J Pediatr Otorhinolaryngol 69:1359-65. 2005
    ..a treatment with xylometazoline, but with the distinction that with EMS the length of use was not restricted, there were not the potential side effects of nasal decongestants, and there was no contraindication in the newborn and infants.
  10. ncbi Nasal wall compliance in vasomotor rhinitis
    Jean François Papon
    Physiopathologie et Thérapeutique Respiratoires INSERM UMR 651, Creteil, France
    J Appl Physiol 100:107-11. 2006
    ....
  11. ncbi Comparison of decongestive capacity of xylometazoline and pseudoephedrine with rhinomanometry and MRI
    M Caenen
    Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Free University Brussels, Brussels, Belgium
    Rhinology 43:205-9. 2005
    ..However, there was no decongestive effect whatsoever on the mucosa of the sinuses with either sympathicomimetic...
  12. ncbi [Investigation of the effect of oxymetazoline on the duration of rhinitis]
    S Reinecke
    MMW Fortschr Med 147:46. 2005
  13. ncbi Improving the management and quality of life of patients with allergic rhinitis
    Victoria Carr
    National Heart and Lung Institute, Imperial College London
    Prof Nurse 20:31-3. 2005
    ..This paper looks at the main causes of allergic rhinitis and its symptoms, and describes the available treatments to manage the conditon...
  14. ncbi Simultaneous analysis of the H1-antihistamine acrivastine and the decongestant pseudoephedrine hydrochloride by high-performance liquid chromatography
    Xiaochen Gu
    Faculty of Pharmacy, University of Manitoba, 50 Sifton Road, Winnipeg, Manitoba, Canada R3T 2N2
    J Pharm Biomed Anal 37:663-7. 2005
    ..This method was used to assay various samples from studies of the commercial preparation Semprex-D capsules. The method was found to be accurate, specific, selective, rapid, and versatile for use in routine quality control analyses...
  15. ncbi [Acute exposure to imidazoline derivatives in children]
    Fabio Bucaretchi
    Universidade Estadual de Campinas UNICAMP, Campinas, SP, Brazil
    J Pediatr (Rio J) 79:519-24. 2003
    ..To study acute exposure to imidazoline derivatives in 72 children younger than 15 years of age, followed-up from January 1994 to December 1999...
  16. ncbi Characterization of nasal obstruction in the allergic guinea pig using the forced oscillation method
    Robbie L McLeod
    Department of Allergy, Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033 0539, USA
    J Pharmacol Toxicol Methods 48:153-9. 2002
    ..This is the first report to evaluate changes in nasal resistance in a preclinical animal model using the forced oscillation method...
  17. ncbi Intranasal drug delivery: an alternative to intravenous administration in selected emergency cases
    Timothy R Wolfe
    Division of Emergency Medicine, University of Utah School of Medicine, Salt Lake City, USA
    J Emerg Nurs 30:141-7. 2004
  18. ncbi Control of nasal obstruction in perennial allergic rhinitis
    De Yun Wang
    Department of Otolaryngology, Faculty of Medicine, National University of Singapore
    Curr Opin Allergy Clin Immunol 4:165-70. 2004
    ..Nasal obstruction in persistent allergic rhinitis must be treated the year round, and therefore treatment choices, costs, and compliance all become important public health issues...
  19. ncbi [Pathologic conditions associated with drug-induced rhinitis]
    Dusanka Milosević
    Zvezdara Department of Otorhinolaryngology, University Hospital Centre, Belgrade
    Srp Arh Celok Lek 132:14-7. 2004
    ..In conclusion, the most common pathological conditions for developing rhinitis medicamentosa were chronic inflammatory and structural diseases manifested by permanent nasal obstruction as well as acute upper respiratory infections are...
  20. ncbi Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray
    Andrea H S Loewen
    Department of Medicine, Faculty of Medicine, University of Calgary, Calgary, Alta
    CMAJ 171:593-4. 2004
    Oxymetazoline is a sympathomimetic amine found in over-the-counter nasal decongestants. We report a case of chronic use of nasal oxymetazoline associated with thunderclap headache due to reversible segmental intracranial vasoconstriction.
  21. ncbi Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis
    William W Storms
    University of Colorado Health Sciences Center, Colorado Springs, CO, USA
    J Allergy Clin Immunol 114:S146-53. 2004
    ..Because of the significant detrimental effects of nocturnal rhinitis symptoms on quality of life, allergic rhinitis therapies should be evaluated for efficacy in ameliorating nighttime symptoms...
  22. ncbi Effect of treating severe nasal obstruction on the severity of obstructive sleep apnoea
    H A McLean
    Dept of Medicine, Queen's University, 102 Stuart Street, Kingston, ON K7L 3N6, Canada
    Eur Respir J 25:521-7. 2005
    ..In conclusion, treating nasal obstruction reduced mouth breathing during sleep and obstructive sleep apnoea severity, but did not effectively alleviate obstructive sleep apnoea...
  23. ncbi [Efficacy of Derinox assessed with one PNIF (Peak Nasal Inspiratory Flow) in patients suffering from common cold]
    R Peynegre
    , , France
    Ann Otolaryngol Chir Cervicofac 122:246-55. 2005
    ..CONCLUSION: Efficacy of Dérinox(R) was superior to that of P and R for the improvement of the nasal obstruction (PNIF) between T0 and T3h (main criteria) after the first intake in patients suffering from common cold...
  24. ncbi Rhinitis medicamentosa: therapeutic effect of diode laser inferior turbinate reduction on nasal obstruction and decongestant abuse
    Philipp P Caffier
    Department of Otorhinolaryngology, Head and Neck Surgery Charité University Medicine Berlin, Berlin, Germany
    Am J Rhinol 22:433-9. 2008
    ..The purpose of this study was to evaluate long-term outcomes of an outpatient-based diode laser inferior turbinate reduction (ITR) in therapy-refractory rhinitis medicamentosa (RM)...
  25. ncbi Sublingual immunotherapy-induced IL-10 production is associated with changed response to the decongestion test: preliminary results
    Giorgio Ciprandi
    A O U San Martino, Genoa, Italy
    Allergy Asthma Proc 28:574-7. 2007
    ..0016 and p = 0.00294, respectively). This preliminary study provides the first evidence of a changed response to decongestion testing after SLIT that is associated with IL-10 production in patients with PAR...
  26. ncbi Topical treatment of rhinosinusitis
    A Fiocchi
    Melloni Paediatria and the Fatebenefratelli Hospital, Melloni, Milan, Italy
    Pediatr Allergy Immunol 18:62-7. 2007
    ..While saline irrigation, nasal decongestants, steroids, antibiotics, antihistamines and fungicides are all in widespread pediatric use, comparing ..
  27. ncbi Office-based management of allergic rhinitis in adults
    Jeffrey M Lehman
    Department of Allergy and Immunology, University of Tennessee Health Science Center, Memphis, Tenn, USA
    Am J Med 120:659-63. 2007
    ..Controlled studies support the utility of several available treatments that produce fewer symptoms, improve quality of life, and prevent comorbidities...
  28. ncbi Nasal eosinophils and reversibility to the decongestion test in patients with perennial allergic rhinitis
    Giorgio Ciprandi
    Azienda Ospedaliera Universitaria San Martino, Genoa, Italy
    Allergy Asthma Proc 28:292-5. 2007
    ..338). This study provides evidence of a significant association between nasal eosinophils and the reversibility to the decongestion test in patients with PAR...
  29. ncbi Sinonasal disease and nasal saline
    Baran Acar
    Arch Otolaryngol Head Neck Surg 133:625; author reply 625. 2007
  30. ncbi Is acetaminophen as effective as an antihistamine-decongestant-acetaminophen combination in relieving symptoms of acute nasopharyngitis in children? A randomised, controlled trial
    Emin Unuvar
    Department of Pediatrics, Istanbul University, Istanbul Medical Faculty, Capa, TR 34390, Istanbul, Turkey
    Int J Pediatr Otorhinolaryngol 71:1277-85. 2007
    ..To determine the efficiency of drugs, which include antihistaminic-decongestant-acetaminophen agents versus only acetaminophen in symptomatic treatment of acute nasopharyngitis in children...
  31. ncbi Reference values for acoustic rhinometry in decongested school children and adults: the most sensitive measurement for change in nasal patency
    Sune P Straszek
    Department of Environmental and Occupational Medicine, Institute of Public Health, University of Aarhus, Aarhus, Denmark
    Rhinology 45:36-9. 2007
    ..We want to establish a set of reference values for MCA and nasal volumes for both adults and children and include values also for the decongested nose and determine the most sensitive measurement for change in nasal patency...
  32. ncbi Allergic rhinitis: selective comparisons of the pharmaceutical options for management
    Bob Lanier
    Department of Pediatrics Immunology, University of North Texas, Fort Worth, USA
    Allergy Asthma Proc 28:16-9. 2007
    ..This review is intended as an aid in comparing classes and formats of medications affecting nasal allergy...
  33. ncbi Treatment of acute and chronic rhinosinusitis in the United States, 1999-2002
    Hadley J Sharp
    Department of Otolaryngology Head and Neck Surgery, University of Nebraska Medical Center, Omaha 68106, USA
    Arch Otolaryngol Head Neck Surg 133:260-5. 2007
    ....
  34. ncbi Evaluation of protective and therapeutic effects of dexpanthenol on nasal decongestants and preservatives: results of cytotoxic studies in vitro
    Norbert Klöcker
    AUDIT Institute for Medical Services and Quality Assurance, Taunusstein, Germany
    Am J Rhinol 18:315-20. 2004
    More than 600 million units of nasal decongestants are sold worldwide annually...
  35. ncbi A new hydrophilic interaction liquid chromatographic (HILIC) procedure for the simultaneous determination of pseudoephedrine hydrochloride (PSH), diphenhydramine hydrochloride (DPH) and dextromethorphan hydrobromide (DXH) in cough-cold formulations
    Mohammed Shahid Ali
    Jamjoom Pharmaceuticals Company Limited, Industrial Area, Phase 5, Jeddah 21442, Saudi Arabia
    J Pharm Biomed Anal 43:158-67. 2007
    ..Mobile phase pH is manipulated to regulate ionization and ion-exchange interaction and thereby retention of compounds...
  36. ncbi Decongestion test in patients with allergic rhinitis: functional evaluation of nasal airflow
    Giorgio Ciprandi
    Ospedale San Martino, Genoa, Italy
    Am J Rhinol 20:224-6. 2006
    ....
  37. ncbi Medical management and diagnosis of chronic rhinosinusitis: A survey of treatment patterns by United States otolaryngologists
    Scott M Kaszuba
    Bobby R. Alford Department of Otorhinolaryngology and Communicative Sciences, Baylor College of Medicine, Houston, Texas, USA
    Am J Rhinol 20:186-90. 2006
    ..S. otolaryngologists agree on the use of oral antibiotics and nasal corticosteroids as part of maximal medical management for CRS but do not agree on other adjuvant therapies or on the use of endoscopy as a diagnostic criterion...
  38. ncbi Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis
    Gordon D Raphael
    Pfizer Consumer Healthcare, Morris Plains, New Jersey 07950, USA
    Ann Allergy Asthma Immunol 96:606-14. 2006
    ..Somnolence occurred more frequently with diphenhydramine (22.1%) compared with desloratadine (4.5%) and placebo (3.4%)...
  39. ncbi Association between response to decongestion testing and sensitizations and allergic inflammation
    Giorgio Ciprandi
    Dipartimento Patologie Testa Collo, Padiglione Specialità piano terzo, Azienda Ospedale Università San Martino, Genoa, Italy
    Ann Allergy Asthma Immunol 96:431-6. 2006
    ..Rhinomanometry is used to measure nasal airflow, which is frequently impaired in allergic rhinitis (AR). Decongestion testing consists of spraying an intranasal vasoconstrictor drug to evaluate recovery of nasal airflow...
  40. ncbi [The tolerability of nasal drugs with special regard to preservatives and physico-chemical parameters]
    Th Verse
    Universitäts Hals Nasen Ohrenklinik Mannheim
    Laryngorhinootologie 82:782-9. 2003
    ..New pharmaceutical formulations for better tolerable nasal sprays are now possible and consequently reformulations introduced to the market. Therefore, a representative and systematic overview on comparable products is mandatory...
  41. ncbi Intranasal application of the alpha2-adrenoceptor agonist BHT-920 produces decongestion in the cat
    R L McLeod
    Allergy, Schering-Plough Research Institute, Kenilworth, New Jersey 07033-0539, USA
    Am J Rhinol 15:407-15. 2001
    ..3 and 1.0% lasted over 60 minutes. The present findings indicate that selective alpha2-agonists may produce decongestant activity with an improved cardiovascular profile compared with current sympathomimetic drugs such as phenylephrine...
  42. ncbi Pregnancy rhinitis and rhinitis medicamentosa
    Betty Rambur
    College of Nursing and Health Sciences, University of Vermont in Burlington, VT, USA
    J Am Acad Nurse Pract 14:527-30. 2002
    ..To present guidelines for the recognition, management, and referral of pregnancy rhinitis with a goal of improving the quality of the pregnancy experience for women afflicted with this condition...
  43. ncbi Canine model of nasal congestion and allergic rhinitis
    Ruslan L Tiniakov
    University of Illinois at Chicago, and Veterans Affairs Chicago Health Care System, Chicago, Illinois 60612, USA
    J Appl Physiol 94:1821-8. 2003
    ....
  44. ncbi Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion
    U P Stübner
    Ear Nose Throat University Clinic, Vienna, Austria
    Arzneimittelforschung 51:904-10. 2001
    ..With the exception of nasal obstruction, all subjective symptoms as well as the global condition were significantly better under CTZ/PSE. Amounts of nasal secretions during these sessions were significantly lower with CTZ/PSE...
  45. ncbi [The relationship between ostial patency and medical treatment in acute maxillary sinusitis: an experimental study]
    Ahmet Kutluhan
    Department of Otolaryngology, Medicine Faculty of Yüzüncü Yıl University, Van, Turkey
    Kulak Burun Bogaz Ihtis Derg 9:275-81. 2002
    ..We investigated the relationship between ostial patency and medical treatment in an experimental model of acute maxillary sinusitis...
  46. ncbi Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit
    Robert B Berkowitz
    RxResearch, Woodstock, Georgia 30188, USA
    Ann Allergy Asthma Immunol 89:38-45. 2002
    ..4% for fexofenadine-pseudoephedrine and 3.3% for placebo. CONCLUSIONS: Fexofenadine-pseudoephedrine was safe and effective in treating a broad range of allergy symptoms, with a rapid onset of action at 45 minutes...
  47. ncbi Improved strategies and new treatment options for allergic rhinitis
    Sandra K Willsie
    University of Health Sciences College of Osteopathic Medicine in Kansas City, MO, USA
    J Am Osteopath Assoc 102:S7-14. 2002
    ..Future therapeutic options include leukotriene modifiers and anti-IgE antibodies...
  48. ncbi Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study
    F Castellano
    IBSA Institut Biochimique S.A, 6915 Pambio-Noranco, Switzerland
    Drugs Exp Clin Res 28:27-35. 2002
    ..1%. HA seems to act as an enhancer/carrier of the active principle, xylometazoline, as already demonstrated for other drugs. The new formulation at a concentration of 0.05% was therefore selected for further clinical development...
  49. ncbi Hypertonic saline nasal provocation and acoustic rhinometry
    J N Baraniuk
    Division of Rheumatology, Immunology and Allergy, Georgetown University, Washington, DC 20007, USA
    Clin Exp Allergy 32:543-50. 2002
    ..Hypertonic saline (HTS) acts as an airway irritant in human nasal mucosa by stimulating nociceptive nerves and glandular secretion. HTS does not change vascular permeability. In asthma, HTS causes airflow obstruction...
  50. ncbi The effect of intranasal budesonide spray on mucosal blood flow measured with laser Doppler flowmetry
    A Cervin
    Department of Oto-Rhino-Laryngology, Head and Neck Surgery, University of Lund, S-221 85 Lund, Sweden
    Rhinology 39:13-6. 2001
    ..9 +/- 7.1% measured from baseline values. CONCLUSION: A single dose of intranasal budesonide aqueous nasal spray has no acute effects on nasal septal mucosal blood flow...
  51. ncbi The effect of inferior turbinate hypertrophy on nasal spray distribution to the middle meatus
    A C Dowley
    Department of Otolaryngology-Head and Neck Surgery, Hull Royal Infirmary, Hull, UK
    Clin Otolaryngol Allied Sci 26:488-90. 2001
    ..026). This may support a clinical role for inferior turbinate reduction to improve the efficacy of topical nasal therapy, as well as improving nasal airflow...
  52. ncbi [Advance in therapy of acute rhinitis--comparison of efficacy and safety of xylometazoline in combination xylometazoline-dexpanthenol in patients with acute rhinitis]
    W Kehrl
    Klinik und Ambulatorium für Hals Nasen Ohren Krankenheiten, Katholisches Marienkrankenhaus, Hamburg
    Laryngorhinootologie 82:266-71. 2003
    ..After proving a synergistic effect of Xylometazoline and Dexpanthenol (Nasic) in patients after nasal surgery, this result should be checked in patients with acute non-allergic rhinitis...
  53. ncbi Chronic cough. Article is not consistent with WHO initiative on rhinitis and asthma
    Mike Thomas
    BMJ 326:1036. 2003
  54. ncbi Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray
    Sandra Gawchik
    Asthma and Allergy Associates, Upland, Pennsylvania, USA
    Ann Allergy Asthma Immunol 90:416-21. 2003
    ..Mometasone furoate nasal spray (MFNS, Nasonex, Schering, Kenilworth, NJ), an anti-inflammatory nasal corticosteroid, has been shown to be safe and effective in reducing the nasal inflammation of SAR...
  55. ncbi [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis]
    M Dorn
    Casore del Monte, Toscana-Italien
    HNO 51:794-9. 2003
    ..CONCLUSION. Preparations without preservatives should be the preferred choice of treatment for acute rhinitis...
  56. ncbi Efficacy and safety of clemastine-pseudoephedrine-acetaminophen versus pseudoephedrine-acetaminophen in the treatment of seasonal allergic rhinitis in a 1-day, placebo-controlled park study
    Eli O Meltzer
    Allergy and Asthma Medical Group and Research Center, San Diego, California, USA
    Ann Allergy Asthma Immunol 90:79-86. 2003
    ..Patients with allergic rhinitis have a wide range of symptoms that are often treated with oral combination products that contain antihistamines, decongestants, and analgesics...
  57. ncbi Allergic rhinoconjunctivitis in elite athletes: optimal management for quality of life and performance
    Constance H Katelaris
    Institute of Immunology and Allergy Research, Westmead Hospital, Westmead 2145, Sydney, New South Wales, Australia
    Sports Med 33:401-6. 2003
    ..Since avoidance strategies are rarely practical for the athlete, consideration should be given to strategies such as immunotherapy, where long-term benefit is possible...
  58. ncbi The vascular effects of trace amines and amphetamines
    Kenneth J Broadley
    Division of Pharmacology, Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cathays Park, Cardiff CF10 3NB, UK
    Pharmacol Ther 125:363-75. 2010
    ..This effect is the basis of their use as nasal decongestants. For over 50 years, they have been assumed to be indirectly acting sympathomimetic amines, their responses ..
  59. ncbi [Drugs and drug abusers]
    J Schlatter
    Service Pharmacie Toxicologie, Centre Hospitalier Universitaire Jean Verdier, Avenue du 14 Juillet, F 93140 Bondy
    Presse Med 30:282-7. 2001
    ..Clinical signs of addiction and weaning are observed. OTHERS: Several other drug classes are used by abusers, including analgics, beta-adrenergic agents, nasal vasoconstrictors and corticosteroids...
  60. ncbi Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline
    Britta Haenisch
    University of Bonn, Institute of Pharmacology and Toxicology, D 53113 Bonn, Germany
    Fundam Clin Pharmacol 24:729-39. 2010
    ..e. at receptors highly expressed at the mRNA level in human nasal mucosa, could eventually explain why in nasal decongestants oxymetazoline can be used in lower concentrations than xylometazoline.
  61. ncbi Cytotoxic effects of 110 reference compounds on HepG2 cells and for 60 compounds on HeLa, ECC-1 and CHO cells. II mechanistic assays on NAD(P)H, ATP and DNA contents
    Willem G E J Schoonen
    Department of Pharmacology, N V Organon, Molenstraat 110, 5340 BH Oss, The Netherlands
    Toxicol In Vitro 19:491-503. 2005
    ..These compounds were non-narcotic antitussives, nasal decongestants, narcotic analgesics, hypnotics, vasodilators, specific cellular energy blockers, cellular proliferation ..
  62. ncbi The effectiveness of nasal decongestants, oral decongestants and oral decongestant-antihistamines in the treatment of acute otitis media in children
    Ahmet Eyibilen
    Department of Otolaryngology, Medicine Faculty of Gaziosmanpaşa University, Tokat, Turkey
    Kulak Burun Bogaz Ihtis Derg 19:289-93. 2009
    The aim of this study was to evaluate the effectiveness of nasal decongestants, oral decongestants and oral decongestant-antihistamines in the treatment of acute otitis media and resolution of the middle ear effusion in children.
  63. ncbi [Reversible cerebral vasoconstriction syndrome]
    Anne Ducros
    Centre d Urgences Céphalées, Pôle neurosensoriel tête et cou, APHP, Hopital Lariboisiere, F 75010 Paris, France
    Presse Med 39:312-22. 2010
    ..g., cannabis, antidepressants, and nasal decongestants) or occur in the postpartum period...
  64. ncbi The role of the nose in the pathogenesis of obstructive sleep apnoea and snoring
    M Kohler
    Oxford Centre for Respiratory Medicine, Oxford OX3 7LJ, UK
    Eur Respir J 30:1208-15. 2007
    ..External nasal dilators were used in five studies, topically applied steroids in one, nasal decongestants in two, and surgical treatment in one study...
  65. ncbi Surgery for severe rhinosinusitis
    E Bradley Strong
    Department of Otolaryngology, University of California, Davis, School of Medicine, 2521 Stockton Boulevard, Suite 7200, Sacramento, CA 95817, USA
    Clin Rev Allergy Immunol 25:165-76. 2003
    ..This includes a 4-6 wk course of oral antibiotics, nasal steroids, topical nasal decongestants, and oral prednisone if possible...
  66. ncbi Gonadotropin-releasing hormone analogs: update on new findings
    M R Henzl
    Syntex Research, Palo Alto, California
    Am J Obstet Gynecol 166:757-61. 1992
    ..In one series of studies, the effect of nasal mucosal inflammation and the concomitant use of nasal decongestants on the nasal absorption of nafarelin was evaluated in women with perennial rhinitis...
  67. ncbi The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients
    Anne Ducros
    Emergency Headache Centre, Lariboisiere Hospital, 2 rue Ambroise Pare, 75010 Paris, France
    Brain 130:3091-101. 2007
    ..to various vasoactive substances in 37, mainly cannabis, selective serotonin-recapture inhibitors and nasal decongestants. The main pattern of presentation (94% of patients) was multiple thunderclap headaches recurring over a ..
  68. ncbi The role of the nose in the pathogenesis of obstructive sleep apnea
    Malcolm Kohler
    Pulmonary Division, University Hospital of Zurich, Zurich, Switzerland
    Curr Opin Otolaryngol Head Neck Surg 17:33-7. 2009
    ....
  69. ncbi Rhinitis medicamentosa: electron microscopic changes of human nasal mucosa
    Stephan Knipping
    Department of Otorhinolaryngology Head and Neck Surgery, The Martin Luther University Halle Wittenberg, Germany
    Otolaryngol Head Neck Surg 136:57-61. 2007
    ..Nasal obstruction is induced by rebound swelling when the decongestive effect has disappeared. The aim of this study was to demonstrate ultrastructural changes in RM...
  70. ncbi Phenylpropanolamine decreases food intake in rats made hyperphagic by various stimuli
    F A Moya-Huff
    Department of Pharmacology, Massachusetts College of Pharmacy, Boston 02115
    Pharmacol Biochem Behav 28:71-4. 1987
    Phenylpropanolamine (PPA, d,l-norephedrine), found in many over-the-counter appetite suppressants and nasal decongestants, induces anorexia by a yet unidentified mechanism...
  71. ncbi Efficacy of isotonic nasal wash (seawater) in the treatment and prevention of rhinitis in children
    Ivo Slapak
    Pediatric Otorhinolaryngology Clinic, Teaching Hospital Brno, Czech Republic
    Arch Otolaryngol Head Neck Surg 134:67-74. 2008
    ..To evaluate the potential of nasal isotonic saline application to prevent reappearance of cold and flu in children during the winter...
  72. ncbi [Rhinosinusitis in childhood]
    G Caramia
    Primario Emerito di Pediatria e Neonatologia Azienda Ospedaliera Materno Infantile G Salesi, Ancona
    Pediatr Med Chir 27:42-9. 2005
    ..Some researcers demonstrated the effectiveness of this approach, also preventig otitis. Nasal decongestants and antinflammatories are useful, too...
  73. ncbi Sleep and allergic rhinitis
    J Muliol
    Rhinology Unit and Smell Clinic, ENT Department, Hospital Clinic, Barcelona, Spain
    J Investig Allergol Clin Immunol 18:415-9. 2008
    ..of sleep in allergic rhinitis by using medications (antihistamines, topical nasal corticosteroids, nasal decongestants, antileukotrienes) and, finally, the relationship between the sleep apnea syndrome with allergic rhinitis ..
  74. ncbi Secondhand tobacco smoke exposure and chronic rhinosinusitis: a population-based case-control study
    Douglas D Reh
    Department of Otolaryngology Head and Neck Surgery, Johns Hopkins Sinus Center, Johns Hopkins Medicine, Baltimore, Maryland 21287, USA
    Am J Rhinol Allergy 23:562-7. 2009
    ..To address this evidence gap, we evaluated the association of SHS and CRS risk in a community-based case-control study of adult nonsmokers...
  75. ncbi Toxicity of drugs used for treatment of rhinitis: a reminder to the otorhinolaryngologist
    A P Balbani
    Otorhinolaryngology Department, University of Sao Paulo Medical School, Brazil
    Am J Rhinol 14:77-82. 2000
    ..05) and a preponderance among males aged 5-9 years and females aged 10-39 years. Accidental intake of medicines accounted for the majority of toxicity cases (57.2%)...
  76. ncbi Chronic rhinosinusitis gives a ninefold increased risk of chronic headache. The Akershus study of chronic headache
    K Aaseth
    Head and Neck Research Group, HØKH, Research Centre, Akershus University Hospital, Lørenskog
    Cephalalgia 30:152-60. 2010
    ..surgery, nasal corticosteroids, discontinuation of overused headache medications and discontinuation of nasal decongestants or unspecified reasons...
  77. ncbi Does inhaling menthol affect nasal patency or cough?
    Priti Kenia
    Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
    Pediatr Pulmonol 43:532-7. 2008
    ..There is widespread use of menthol in over-the-counter medications, despite scant information on any beneficial effects. Our aim was to assess the effect of menthol on nasal air flow, perception of nasal patency and cough challenge testing...
  78. ncbi Clinical assessment of nasal decongestion test by VAS in adolescents
    Gian Luigi Marseglia
    Dipartimento di Scienze Pediatriche, Università di Pavia Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
    Pediatr Allergy Immunol 20:187-91. 2009
    ..In conclusion, the use of VAS appears as clinically relevant, in that it allows, with a fair reliability, to perform the decongestion test in the absence of rhinomanometry...
  79. ncbi Effects on nasal nitric oxide production of 2 mechanisms of vasoconstriction
    C Serrano
    Allergy Unit, Foundation, Valle del Lili Cali, Colombia
    J Investig Allergol Clin Immunol 17:337-40. 2007
    ..It is as yet unclear if this last finding is due to the effects of the drug on the enzyme or on the vessels. Physical exercise also induces nasal vasoconstriction and reduces nasal resistance...
  80. ncbi Allergic rhinitis--current pharmacotherapy
    John H Krouse
    Rhinology and Allergy, Department of Otolaryngology, Wayne State University, 540 E Canfield, 5E UHC, Detroit, MI 48201, USA
    Otolaryngol Clin North Am 41:347-58, vii. 2008
    ..Through an appreciation of these various physiological mechanisms, the physician can select the treatment option or options that will be most likely to effectively manage symptoms...
  81. ncbi Treating common problems of the nose and throat in pregnancy: what is safe?
    Petros V Vlastarakos
    ENT Department, Hippokrateion General Hospital of Athens, 29 Dardanellion str, Glyfada Athens, 16562 Athens, Greece
    Eur Arch Otorhinolaryngol 265:499-508. 2008
    ..Non-selective NSAIDs (until the 32nd week), nasal decongestants (with caution and up to 7 days), intranasal corticosteroids, with budesonide as the treatment of choice, ..
  82. ncbi Effect of nasal spray, positional therapy, and the combination thereof in the asymptomatic snorer
    H M Braver
    University of Florida College of Medicine, Gainesville
    Sleep 17:516-21. 1994
    ..There was no significant change in snoring using any of these general measures...
  83. ncbi Treating common ear problems in pregnancy: what is safe?
    Petros V Vlastarakos
    ENT Department, Hippokrateion General Hospital of Athens, 114 Vas Sofias Av, Athens, Greece
    Eur Arch Otorhinolaryngol 265:139-45. 2008
    ..Non-selective NSAIDs (until the 32nd week), nasal decongestants (with caution and up to 7 days), intranasal corticosteroids, with budesonide as the treatment of choice, ..
  84. ncbi Home medication cabinets and self-medication: a source of potential health threats?
    Leen De Bolle
    Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
    Ann Pharmacother 42:572-9. 2008
    ..Data regarding the contents of home medication cabinets (HMCs), the management of leftover medications, and the inclination of patients toward self-initiated treatment using nonprescription drugs are scarce...
  85. ncbi The pathophysiology, clinical impact, and management of nasal congestion in allergic rhinitis
    Robert A Nathan
    Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado, USA
    Clin Ther 30:573-86. 2008
    ..Nasal congestion is a cardinal symptom of allergic rhinitis (AR). It is difficult to treat and is associated with decreased quality of life...
  86. ncbi Overview of the treatment of allergic rhinitis and nonallergic rhinopathy
    Alexander N Greiner
    Allergy and Asthma Medical Group and Research Center, 5776 Ruffin Road, San Diego 92123 Suite B, San Diego, CA 92123, USA
    Proc Am Thorac Soc 8:121-31. 2011
    ..Furthermore, treatment algorithms for AR and NAR are presented with a stepped-up, stepped-down scheme to aid the clinician in choosing appropriate therapy...
  87. ncbi Adverse events from cough and cold medications after a market withdrawal of products labeled for infants
    Nadine Shehab
    Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, Mailstop A 24, Atlanta, GA 30333, USA
    Pediatrics 126:1100-7. 2010
    ..The goal of this study was to assess CCM-related adverse events (AEs) among children after the withdrawal...
  88. ncbi Prognostic value of anterior rhinomanometry in diode laser turbinoplasty
    Gerd Fabian Volk
    Department of Otorhinolaryngology, Friedrich Schiller Universitat, Lessingstraße 2, D 07743 Jena, Germany
    Arch Otolaryngol Head Neck Surg 136:1015-9. 2010
    ..To identify objective criteria predicting the success of diode laser-assisted turbinoplasty...
  89. ncbi Effects of orthopedic rapid maxillary expansion on internal nasal dimensions in children with cleft lip and palate assessed by acoustic rhinometry
    Inge Elly Kiemle Trindade
    Bauru School of Dentistry and daggerHospital for Rehabilitation of Craniofacial Anomalies, University of Sao Paulo, Bauru, Sao Paulo, Brazil
    J Craniofac Surg 21:306-11. 2010
    ..The findings contribute toward the characterization of nasal deformities determined by the cleft and demonstrate the positive effect RME had on nasal morphophysiology in a significant number of the patients who underwent this procedure...
  90. ncbi Are nasal decongestants safer than rhinitis? A case of oxymetazoline-induced syncope
    Marianna Fabi
    Pediatric Cardiology and Adult Congenital Unit, University of Bologna, Ospedale S Orsola Malpghi, Via Massarenti 9, Bologna BO, Italy
    Cardiol Young 19:633-4. 2009
    ..These medications do not require medical prescriptions, so often parents use them, bypassing paediatricians. We report here a case of cardiovascular and neurological depression induced by oxymetalzoline in a toddler...
  91. ncbi Efficacy of targeted medical therapy in chronic rhinosinusitis, and predictors of failure
    Devyani Lal
    Department of Otolaryngology Head and Neck Surgery, Loyola University Medical Center, Maywood, Illinois 60153, USA
    Am J Rhinol Allergy 23:396-400. 2009
    ..quot; The objectives of this study were to determine efficacy of a standardized targeted medical therapy (TMT) regimen in CRS and to analyze factors associated with failure of therapy...
  92. ncbi Parental misinterpretations of over-the-counter pediatric cough and cold medication labels
    Nicole Lokker
    Department of Pharmacy, University of Wisconsin Hospital and Clinics, Madison, Wisconsin, USA
    Pediatrics 123:1464-71. 2009
    ..Our goal was to examine caregiver understanding of the age indication of over-the-counter cold medication labels and identify factors, associated with caregiver understanding...
  93. ncbi Self-medication in nursing mothers and its influence on the duration of breastfeeding
    Roberto G Chaves
    Ciências da Saúde Saúde da Criança e do Adolescente, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
    J Pediatr (Rio J) 85:129-34. 2009
    ..To investigate the practice of self-medication by nursing mothers, the main drugs used and the influence on the duration of breastfeeding...
  94. ncbi Pediatric fatalities associated with over the counter (nonprescription) cough and cold medications
    Richard C Dart
    Rocky Mountain Poison and Drug Center, Denver Health and Hospital Authority, Denver, CO 80204, USA
    Ann Emerg Med 53:411-7. 2009
    ..We evaluate the role of these medications in pediatric fatalities and identified factors that contributed to the death...
  95. ncbi Congenital nasal pyriform aperture stenosis: diagnosis and management
    Marion Devambez
    Department of Otolaryngolog Head and Neck Surgery, University Hospital of Lille, France
    Cleft Palate Craniofac J 46:262-7. 2009
    ..To review diagnosis and treatment modalities in congenital nasal pyriform aperture stenosis in a newborn population. Study Design: A 6-year retrospective case series review. Mean follow-up of 21.8 months...
  96. ncbi The effects of inhaled L-methamphetamine on athletic performance while riding a stationary bike: a randomised placebo-controlled trial
    F Dufka
    Addiction Pharmacology Lab, California Pacific Medical Center Research Institute, 3555 Cesar Chavez, San Francisco, CA 94110, USA
    Br J Sports Med 43:832-5. 2009
    ..This study tested the effects of inhaled L-methamphetamine delivered from a widely available non-prescription product on athletic performance...
  97. ncbi Mechanism of false-negative urine cannabinoid immunoassay screens by Visine eyedrops
    S D Pearson
    Department of Pathology, University of Utah School of Medicine, Salt Lake City 84132
    Clin Chem 35:636-8. 1989
    ....
  98. ncbi A randomized, controlled trial of nasal phenylephrine in infants hospitalized for bronchiolitis
    Shawn Ralston
    Department of Pediatrics, Community Medical Center, Missoula, MT, USA
    J Pediatr 153:795-8. 2008
    ..To examine the hypothesis that pharmacologic treatment of nasal obstruction, specifically alpha-adrenergic nose drops, will decrease objective signs of respiratory distress in infants with bronchiolitis...
  99. ncbi The use of drugs by UK recreational divers: prescribed and over-the-counter medications
    Marguerite St Leger Dowse
    Diving Diseases Research Centre, Hyperbaric Medical Centre, Plymouth, Devon, United Kingdom
    Diving Hyperb Med 41:16-21. 2011
    ..As part of a diversion in a study of illicit drug use in sport divers, secondary data regarding the use of prescribed and over-the-counter medications were gathered...
  100. ncbi Ischemic stroke in a man with naphazoline abuse history
    Giorgio Costantino
    Medicina Interna II, L. Sacco Hospital, Milan, Italy
    Am J Emerg Med 25:983.e1-2. 2007
  101. ncbi [Rhinitis medicamentosa in cytological assessment of the nasal mucosa]
    Bozena Tarchalska

    Pol Merkur Lekarski 19:288-90. 2005
    ..medicamentosa and evaluation of usefulness of exfoliative cytology in diagnostics of underlying reason of nasal decongestants overuse. All patients had a history of six months regular use of popular intranasal alpha-adrenomimetics...

Research Grants45

  1. XYLITOL FOR ACUTE OTITIS MEDIA PROPHYLAXIS
    Louis Vernacchio; Fiscal Year: 2003
    ..A preliminary estimate of the effect size of xylitol treatment from the pilot RCT will suggest whether the effect if sufficiently large to warrant a large formal RCT to be proposed. ..
  2. Sleep Intervention During Acute Lung Injury
    Sairam Parthasarathy; Fiscal Year: 2010
    ..We will find the best sleep measurement tool and administer a new medication that improves sleep by soothing inflammation which may, in the future, improve the quality of life of patients. ..
  3. MDMA Dependence and Discontinuation Syndrome
    John Mendelson; Fiscal Year: 2007
    ..Addiction to MDMA appears to be a serious risk of use; our studies will carefttlly define important clinical features of this emerging disorder. ..
  4. The Effectiveness of Treatment for Adult Periodontitis
    Philippe Hujoel; Fiscal Year: 2006
    ..This information can help determine in what area of periodontal research definitive clinical trials may offer the greatest contribution. ..
  5. Interleukin-4 effects on calcium in airway smooth muscle
    JOHN MADISON; Fiscal Year: 2005
    ..Studies will be done with freshly-dispersed bovine and cultured human airway smooth muscle cells. ..
  6. Clinical Pharmacology of 3,4-Methylenedioxy Amphetamines
    John E Mendelson; Fiscal Year: 2010
    ..This experiment will investigate the role of alpha-1 adrenergic receptors in the action of MDMA and will provide preliminary data on the possible use of prazosin in the treatment of acute MDMA toxicity. ..
  7. Sleep Intervention During Acute Lung Injury
    Sairam Parthasarathy; Fiscal Year: 2009
    ..We will find the best sleep measurement tool and administer a new medication that improves sleep by soothing inflammation which may, in the future, improve the quality of life of patients. ..
  8. Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome
    James Baraniuk; Fiscal Year: 2009
    ..These methods and biomarkers may be of diagnostic value. They will be useful for assessing longitudinal changes in disease severity, phenotype, or the effects of treatment. ..
  9. Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome
    James Baraniuk; Fiscal Year: 2007
    ..These methods and biomarkers may be of diagnostic value. They will be useful for assessing longitudinal changes in disease severity, phenotype, or the effects of treatment. ..
  10. CALCIUM REGULATION IN SINGLE AIRWAY SMOOTH MUSCLE CELLS
    JOHN MADISON; Fiscal Year: 2000
    ..To address these aims, the principal method is radiometric imaging of [Ca2+]i in single, bovine airway smooth muscle cells loaded with the calcium dye, fura-2. ..
  11. MECHANISMS OF RHINITIS IN CFS
    James Baraniuk; Fiscal Year: 1999
    ..e. nasal provocation) as the means to evaluate future treatments of CFS. ..
  12. CLINICAL PHARMACOLOGY OF METHAMPHETAMINE STEREOISOMERS
    John Mendelson; Fiscal Year: 2003
    ..Primary outcome measures include drug and metabolite measurements in plasma and urine and subjective and cardiovascular measures, including 2D echocardiography. ..